These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5616188)

  • 1. [Compatibility and action of very high dosage of endoxuan in the treatment of tumors].
    Martini H; Scheef W; Knecht B
    Med Welt; 1967 Jul; 26():1573-8. PubMed ID: 5616188
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the problem of intraoperative cytostatic high dosage therapy in the treatment of cancer. I].
    Kirsch R; Schmidt D; Fichler J
    Zentralbl Chir; 1967 Sep; 92(38):2559-70 contd. PubMed ID: 5595511
    [No Abstract]   [Full Text] [Related]  

  • 3. Relations between polymorphisms in drug-metabolising enzymes and toxicity of chemotherapy with cyclophosphamide, thiotepa and carboplatin.
    Ekhart C; Rodenhuis S; Smits PH; Beijnen JH; Huitema AD
    Pharmacogenet Genomics; 2008 Nov; 18(11):1009-15. PubMed ID: 18854779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On tolerance of high dosage intraoperative cytostatic prophylaxis in cancer].
    Schmidt D; Haym J; Schuh D
    Dtsch Gesundheitsw; 1967 Oct; 22(43):2025-30. PubMed ID: 5600191
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience with high dosage cytostatic "high single dose" therapy of malignant tumors].
    Zerna M; Wolff H
    Bruns Beitr Klin Chir (1971); 1966 Mar; 212(2):146-53. PubMed ID: 5994826
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with the endoxan intensive therapy of malignant tumors].
    Gebhardt KH; Becher R
    Med Welt; 1966 Apr; 17():973-6. PubMed ID: 5985776
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cyclophosphamide and 5-fluoracil in the treatment of inoperable tumors].
    Engell HC; Ulrich K
    Ugeskr Laeger; 1966 Mar; 128(11):325-9. PubMed ID: 5915749
    [No Abstract]   [Full Text] [Related]  

  • 8. [The treatment of pain in patients with inoperable tumors, using xylocaine and cyclophosphamide of nitrogen mustard].
    Caminiti G
    Minerva Anestesiol; 1966 Jan; 32(1):57. PubMed ID: 4160106
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative results of massive endoxan stoss therapy and treatment of malignant tumors with proresid].
    Gebhardt KH; Becher R
    Med Welt; 1967 Jul; 30():1705-7. PubMed ID: 5616405
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results obtained by high doses of cyclophosphamide in solid tumors].
    Bilge N; Aran M
    Turk Tip Cemiy Mecm; 1970 Feb; 36(2):116-27. PubMed ID: 5502530
    [No Abstract]   [Full Text] [Related]  

  • 11. Diphenhydramine provides relief of cyclophosphamide-related symptoms.
    Purl S; Johnson L; Hanauer S; Schroeder L; Proeschel C; Alberts J
    Oncol Nurs Forum; 1996 Apr; 23(3):542. PubMed ID: 8801517
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of 126 cases of advanced ovarian carcinoma with cyclophosphamide.
    Beck RE; Boyes DA
    Can Med Assoc J; 1968 Mar; 98(11):539-41. PubMed ID: 5647240
    [No Abstract]   [Full Text] [Related]  

  • 13. Learning to control cyclophosphamide induced cystitis.
    Hahn NM
    J Urol; 2009 May; 181(5):1987-8. PubMed ID: 19286223
    [No Abstract]   [Full Text] [Related]  

  • 14. [First clinical experiences with ultrahigh single doses of cyclophosphamide].
    Schmitz G; Gross R
    Med Welt; 1967 Apr; 16():985-9. PubMed ID: 5585096
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results with cyclophosphamide therapy in single and massive dosage].
    Helbig W; Mühl H
    Z Gesamte Inn Med; 1967 Dec; 22(24):811-4. PubMed ID: 5585478
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacology of cyclophosphamide and metabolites.
    Colvin M; Hilton J
    Cancer Treat Rep; 1981; 65 Suppl 3():89-95. PubMed ID: 7049370
    [No Abstract]   [Full Text] [Related]  

  • 17. [Toxicity and side effects of cyclophosphamide].
    García Dadoni L; Rafael Seoane M
    Rev Clin Esp; 1968 Apr; 109(1):11-6. PubMed ID: 5738821
    [No Abstract]   [Full Text] [Related]  

  • 18. The course of nausea and vomiting after high-dose cyclophosphamide.
    Fetting JH; Grochow LB; Folstein MF; Ettinger DS; Colvin M
    Cancer Treat Rep; 1982 Jul; 66(7):1487-93. PubMed ID: 7093965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens.
    Ridola V; Fawaz O; Aubier F; Bergeron C; de Vathaire F; Pichon F; Orbach D; Gentet JC; Schmitt C; Dufour C; Oberlin O
    Eur J Cancer; 2009 Mar; 45(5):814-8. PubMed ID: 19216070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose mitoxantrone and cyclophosphamide without stem cell support in high-risk and advanced solid tumors: a phase I trial.
    Pérez-Gracia JL; Colomer R; Ruiz-Casado A; Arcediano A; Tornamira MV; Gómez-Martin C; Valentin V; Mendiola C; Cortés-Funes H; Hornedo J
    Bone Marrow Transplant; 2001 Jan; 27(2):117-23. PubMed ID: 11281378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.